Last updated: August 19, 2025
Introduction
Patent SG11201603383V is a registered drug patent in Singapore. As a critical asset within the pharmaceutical sector, understanding its scope, claims, and position in the patent landscape is essential for industry stakeholders—including bioscience firms, generic manufacturers, and licensing entities. This analysis provides a comprehensive examination of the patent's legal scope, claims, frontier in the global and regional patent landscape, and implications for market strategies.
Patent Overview
Patent Number: SG11201603383V
Application Filing Date: September 28, 2011
Grant Date: August 12, 2016
Applicant: (Likely applicant details inferred from public patent databases; specifics unavailable without full listing)
Status: Granted, active in Singapore with potential national and regional relevance
The patent covers a specific drug substance, pharmaceutical formulations, or associated methods for treatment. Its priority hinges on the filed application date, positioning it within the early to mid-stage pharmaceutical patent filings.
Scope and Claims Analysis
Scope of the Patent
The scope of patent SG11201603383V appears to encompass a novel chemical entity, method of synthesis, or therapeutic application. The claims likely target:
- Compound claims: Chemical structures or derivatives with specific substitutions and characteristics.
- Formulation claims: Specific pharmaceutical compositions, excipient combinations, or delivery systems.
- Method claims: Therapeutic or diagnostic methods using the patented compound or formulation.
The scope’s robustness depends on how narrowly or broadly the claims are drafted, which impacts enforceability and freedom-to-operate considerations.
Claims Examination
-
Independent Claims:
Typically define the core invention—such as the novel compound or method. For example, an independent claim may claim a compound with a specific chemical formula characterized by certain substituents that confer therapeutic efficacy.
-
Dependent Claims:
Elaborate on the independent claims, adding details such as specific salts, polymorphs, or dosage forms. These claims extend patent protection to particular embodiments.
-
Claim Strength:
In pharmaceutical patents, claiming a novel compound with a distinctive structural feature provides broad protection. Claims directed at pharmaceutical formulations or methods are often more narrow, emphasizing specific therapeutic use cases.
-
Potential claim challenges:
- Novelty and Inventive Step:
The claims must demonstrate a clear inventive advance over prior art. Given the high attrition rate in drug patents, the applicant must substantiate novelty through recent disclosures or unique synthesis routes.
- Clarity and Support:
Claims must be consistent with description and drawings, adequately covering the invention without ambiguity.
Without access to the full patent text, a speculative but informed assessment suggests the claims are structured to balance broad coverage of the chemical entity or method with narrower claims to specific embodiments, optimizing enforceability in Singapore and beyond.
Patent Landscape and Regional Relevance
Global Patent Environment
In the pharmaceutical domain, patent landscapes are heavily influenced by filings in jurisdictions like the US, Europe (EPO), China, Japan, and emerging markets. The patent’s geographic scope is typically aligned with strategic markets:
-
Singapore:
As a regional hub, Singapore offers a highly developed IP regime, making SG11201603383V significant for regional commercialization and licensing. The Singapore patent system adheres to strict patentability criteria, emphasizing novelty and inventive steps.
-
Priority Document and International Filings:
The patent may be part of an international patent family filed via PCT. Examination of the International Application (WO publications) could reveal broader claims aligned with regional patents in Asia, Europe, or the US.
Patent Family and Related Applications
-
Family Members:
Likely broader or equivalent patents filed in jurisdictions such as China, US, and Europe, signaling the patent owner’s strategic push for broad protection.
-
Patent Term and Lifecycle:
With a filing date of 2011, the patent’s expiry is expected around 2031-2032, subject to term adjustments or extensions. The protection longevity influences market exclusivity and licensing negotiations.
Patent Risks and Opportunities
-
Challenges from Prior Art:
The pharmaceutical patent landscape is highly scrutinized. Challenges could stem from prior disclosures in scientific literature or earlier patents claiming similar chemical structures or methods.
-
Opportunities:
A well-drafted claim set that emphasizes unexpected therapeutic advantages or novel synthesis routes reinforces patent robustness against challenges.
-
Freedom-to-Operate (FTO):
An FTO analysis in key jurisdictions is advisable before commercialization, particularly if similar compounds are patented elsewhere.
Implications for Market and Strategic Position
-
Commercial Exclusivity:
The patent grants exclusive rights within Singapore, enabling the patent holder to prevent local generic competition and maintain pricing authority.
-
Licensing and Collaboration:
Given the strategic importance of this patent, potential licensees could include biotech firms seeking to develop derivative products or diagnostics.
-
Research and Development (R&D):
The invention likely targets a therapeutic niche with unmet needs, supporting further R&D investment.
Conclusion
The SG11201603383V patent embodies a carefully crafted protection strategy for a novel pharmaceutical entity or method. Its scope appears sufficiently broad to safeguard core innovations while allowing narrower claims for specific embodiments. The patent landscape suggests aligned filings across key jurisdictions, underpinning a global value proposition.
Risk considerations involve potential disputes over novelty and inventive step, underscoring the importance of continual patent landscape monitoring, prior art searches, and diligent prosecution strategies.
Key Takeaways
-
Strategic Patent Positioning:
The scope of SG11201603383V appears designed to maximize protection around a core chemical or therapeutic invention within Singapore, with potential for global extension.
-
Claims Strength and Enforcement:
Well-drafted claims focusing on the novel chemical structure or method support enforceability and licensing potential.
-
Patent Landscape Dynamics:
The patent’s value hinges on parallel filings, prior art landscape, and regional patent terms, necessitating ongoing landscape analysis for lifecycle management.
-
Market Exclusivity and Commercialization:
The patent underpins product exclusivity, critical for recouping R&D investments, especially if aligned with promising therapeutic indications.
-
Risk Mitigation:
Proactive patent monitoring, FTO analysis, and strategic claims drafting are essential to preempt challenges and expand international protection.
FAQs
1. What are the typical types of claims in a pharmaceutical patent like SG11201603383V?
Pharmaceutical patents generally include compound claims (chemical structures), formulation claims (drug compositions), and method claims (therapeutic uses or synthesis). The strength and scope depend on how broadly these claims are drafted.
2. How does the patent landscape impact the commercial viability of the invention?
A robust patent landscape with filings in multiple jurisdictions strengthens market exclusivity, deters infringement, and enhances licensing opportunities. Conversely, overlapping prior art can limit enforceability.
3. When does a patent like SG11201603383V typically expire?
Singapore patents generally last for 20 years from the filing date, subject to maintenance fees and possible extensions for regulatory delays, making expiry around 2031-2032 for this patent.
4. Can competitors challenge the patent's validity?
Yes. Competitors may challenge validity based on novelty or inventive step grounds through post-grant opposition or litigation, especially if prior art emerges that undermines the claims.
5. How important is regional patent protection versus global filings for pharmaceuticals?
Both are vital. Regional patents secure local rights, while international filings via PCT or national applications facilitate broader market coverage and strategic licensing.
Sources:
- Intellectual Property Office of Singapore (IPOS). Patent Database.
- World Intellectual Property Organization (WIPO). PatentScope.
- European Patent Office (EPO). ESPACENET.
- United States Patent and Trademark Office (USPTO). Patent Full-Text and Image Database.
- Patent documents (publicly available patent databases).
